Avery Dennison to expand Medical Product Manufacturing Capabilities in Longford
Published: 3rd May 2018
Avery Dennison Corporation, (NYSE:AVY), a global materials science and manufacturing company, today announced plans to expand its medical product manufacturing operations in Longford, Ireland, increasing the Finesse Medical Ltd., facility’s end-to-end medical device
manufacturing capacity and capabilities for its customers.
Avery Dennison’s Industrial and Healthcare Materials business unit serves customers globally in the development, manufacture and conversion of pressure-sensitive adhesives for medical applications through its Vancive Medical Technologies and Finesse Medical Ltd. businesses.
Project construction is targeted to begin in September 2018, with an expected completion by mid-year 2019. The 6,000 square-meter facility expansion will include a new clean room, integrated converting and manufacturing capabilities. Avery Dennison’s newly expanded facility will enable the company to serve its customers more efficiently with an enhanced array of products and services, and collaborate more effectively with medical OEMs in the development of product innovations.
The project is supported by the Irish Government through IDA Ireland. Avery Dennison expects the capacity expansion to increase employment at the Longford operations over a four-year period.
Minister for Business, Enterprise and Innovation Heather Humphreys TD congratulated the company, saying: “This significant investment by Avery Dennison is a great vote of confidence not only in Longford but also in the Midlands region. This investment, which will result in the creation of additional jobs over the next four years, is a further example of the Government’s commitment to the Regional Action Plan for Jobs. Through the Plan, we are committed to ensuring we have the right conditions and supports in place to encourage job creation right across the country.”
“Avery Dennison Industrial and Healthcare Materials is deeply committed to its medical businesses, to the continued development of its outstanding medical manufacturing capabilities, and to the vibrant professional community here at Longford that has generated this remarkable success story,” said Michael Johansen, vice president and general manager of Avery Dennison’s Industrial and Healthcare Materials business. “We believe that focusing our medical converting manufacturing operations in Longford and investing to build capabilities will open up an exciting array of opportunities, for our company, our customers and our employees.”
CEO, Martin Shanahan, of IDA Ireland said: “News that this global company is to expand its medical product manufacturing operations in Longford is very welcome. It shows a very strong commitment by Avery Dennison to the Longford Finesse Medical site. Winning investment for regional locations is a key focus for IDA Ireland and the resulting increase in employment this expansion will create is very welcome in what is a key region for us. I wish the company every success with this new venture.”
About Avery Dennison
Avery Dennison Corporation (NYSE: AVY) is a global materials science and manufacturing company specializing in the design and manufacture of a wide variety of labeling and functional materials. The company’s products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical and retail applications; tags, labels and embellishments for apparel; and radio-frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in Glendale, California, the company employs approximately 30,000 employees in more than 50 countries. Reported sales in 2017 were $6.6 billion.